Coronary Plaque Screening in Las Vegas: How Dr. Wallace Brucker Uses AI to See Heart Disease Before It Strikes


Most people don't find out they have heart disease until something goes wrong. By the time symptoms appear, the condition has often been building silently for years. For Las Vegas residents who'd rather know early — especially executives whose health is their most valuable asset — Dr. Wallace Brucker, MD at LV Longevity Lab now offers a more direct answer: AI-powered coronary plaque screening that reveals heart disease long before it becomes an emergency.

A Smarter Question Than "What's My Cholesterol?"

For years, the central question in heart health has been about cholesterol. High LDL means elevated risk, and that number drives millions of statin prescriptions every year.

But cholesterol is a surrogate marker — it only suggests risk. It doesn't tell you whether plaque is actually present in your arteries. That distinction is at the heart of Dr. Brucker's approach.

"When we look directly at the arteries, we can put the question of plaque to rest," he explains. Traditional care often commits patients to medication, and its side effects, based on bloodwork alone. Direct imaging replaces that assumption with evidence. If a scan reveals no plaque, it may mean — in the right patient — that a statin isn't necessary or can be reconsidered, rather than taken indefinitely on the basis of a lab value. As always, those decisions are individualized and made under medical supervision, never adjusted independently by the patient.

The Plaques That Standard Tests Miss

Conventional cardiac testing is largely built around stenosis — how much an artery is narrowed. The trouble is that the plaques most likely to rupture and cause a heart attack often don't narrow the artery very much at all.

The research is sobering: in the ICONIC study, more than 75% of the culprit lesions that caused heart attacks were nonobstructive, meaning they blocked less than 50% of the artery. Testing that only looks for blockages overlooks the majority of these high-risk plaques. Direct plaque imaging exists precisely to catch what those tests miss.

What Cleerly and CCTA Actually Measure

The screening relies on Cleerly, an FDA-cleared artificial intelligence platform that analyzes coronary CT angiography (CCTA). Rather than estimating narrowing, Cleerly quantifies the real amount and composition of plaque across the coronary arteries — calcified and noncalcified alike.

The technology has been validated against expert readers, invasive angiography, and other gold-standard references. CCTA itself is remarkably accurate: a meta-analysis of 42 studies and 1,360 patients found 93% sensitivity and 92% specificity. Patients get a direct, objective picture of their coronary health instead of a probability estimate.

Four Stages That Predict Your Future Risk

What makes the results actionable is staging. A system published in the Journal of Cardiovascular Computed Tomography in 2022 classifies coronary disease into four stages by plaque volume, from Stage 0 (no measurable plaque) to Stage 3 (severe).

A 2023 study in JACC: Cardiovascular Imaging, which followed patients for a median of more than 10 years, showed how much those stages matter:

  • Stage 3 patients had more than triple the risk of major adverse cardiac events.
  • Those with the highest noncalcified plaque levels had a fourfold higher risk.
  • Adding AI plaque analysis to standard risk factors and calcium scoring improved 10-year prediction (AUC 0.82 vs. 0.73).

The most encouraging finding: patients with no measurable plaque experienced essentially no cardiac events throughout the study. A clear stage either flags a problem early enough to act on — or delivers genuine, evidence-based reassurance.

Built Into a Complete Longevity Plan

At LV Longevity Lab, cardiac screening isn't a one-off test. Dr. Brucker folds plaque data into a broader, scientifically structured longevity plan alongside advanced bloodwork, metabolic and inflammatory markers, hormone evaluation, and fitness testing. Because plaque can be re-measured, patients can verify whether their plan is working and refine it over time.

It's a model tailored to people who make data-driven decisions in every other part of their lives and expect the same rigor for their health — particularly the Las Vegas executives Dr. Brucker frequently serves.

See Your Heart Clearly

Candidacy for coronary plaque screening is determined individually through a comprehensive medical evaluation. To learn more about AI-powered cardiac screening and longevity care in Las Vegas, visit LV Longevity Lab and schedule a consultation with Dr. Wallace Brucker.

Location: Las Vegas, NV, USA

Popular posts from this blog

Dr John Spencer Ellis Helps Men Over 40 Escape the Rat Race and Attain Optimal Health

  Dr. John Spencer Ellis, a renowned entrepreneur and coach with over three decades of experience, specializes in helping men over 40 break free from the corporate 9-to-5 grind and achieve optimal health. Through his coaching programs, online courses, and mentorship, Ellis guides clients toward financial independence and a healthier lifestyle by fostering entrepreneurship and location-independent businesses.  His approach emphasizes practical minimalism, encouraging men to simplify their lives, reduce expenses, and focus on passions rather than material pursuits. By teaching strategies like building online businesses, creating passive income streams, and leveraging skills in consulting or coaching, he empowers clients to escape the monotony of traditional jobs and live on their terms, whether traveling or working remotely. On the health front, Ellis integrates fitness and wellness into his programs, recognizing that physical vitality enhances professional success. His tailore...
Read more

Dr John Spencer Ellis Reveals The Real Science Behind Men's Longevity: What Actually Extends Your Healthspan

Image
  If you've spent any time on social media lately, you've seen the longevity gurus. They're promising you'll live to 120, selling stacks of exotic supplements, and promoting protocols that sound more like science fiction than medicine. But strip away the marketing hype and ask the hard question: what does credible research actually prove extends lifespan and healthspan for men?   Let's dig into the evidence. Why Most Longevity Advice Misses the Mark The longevity industry has a dirty secret: most interventions being sold lack convincing human evidence. Social media influencers promote compounds that showed promise in mice or petri dishes, but human data is either absent or contradictory. Meanwhile, the interventions with the strongest evidence—the ones that could actually add quality years to your life—are largely ignored because they're not sexy or profitable. Researchers emphasize that holistic practices like physical activity, dietary patterns, and social...
Read more

John Spencer Ellis on Why Men Over 40 Need to Finally Invest in Themselves

Image
  You've spent two decades investing in everything except yourself. The career got your best hours. The family got your weekends. The mortgage got your financial margin. The obligations got whatever remained. Every decision filtered through the same question: what do others need from me? Now you're somewhere past 40, and the account you've been withdrawing from—your own health, energy, and wellbeing—is overdrawn . The body is breaking down. The mind is foggy. The motivation that once felt automatic has disappeared. You've been so busy providing for everyone else that you forgot to maintain the person doing the providing.   This isn't selfishness catching up with you. It's self-neglect. And it's hitting men over 40 with brutal consistency. The Provider Trap and Men's Health Men are conditioned to measure their worth through what they provide. Financial security. Stability. Problem-solving. Strength others can lean on. This conditioning works well en...
Read more